A Randomised Control Study To Compare The Efficacy Of Intravitreal Faricimab6.0 mg Versus Aflibercept 2.0 mg In Management of Treatment Naive Diabetic Macular Edema In Indian Population

It will be a Randomised Controlled Study. The Study will be carried out at Department of Ophthalmology ,Army Hospital Research and Referral New Delhi . The study Population will be patients diagnosed with Diabetic Macular Edema . Diabetic Macular Edema stands as a significant Sight-Threatening complication of Diabetic Retinopathy, contributing substancially to the global burden of visual impairment. The aim of this study is to compare the Efficacy of Intravitreal Faricimab 6.0MG And Aflibercept 2.0MG in Treatment Naive Diabetic Macular Edema by observing the improvement in Best corrected Visual Acuity , reduction in Central Macular Thickness and to study whether Faricimab is able to achieve Longer Inter-injection Interval.Patients will be examined at 0,4 and 8 weeks and all patients meeting the inclusion criteria will receive loading doses as per the group in which they are assigned  and will be followed up at 4 weekly interval. Decision for Retreatment will be taken after 4 weeks of injection on the basis of worsening of Visual Acuity and Increase in Central Macular Thickness.